Multivariate analysis of acute GVHD
Variable . | GVHD II-IV . | GVHD III-IV . | ||||
---|---|---|---|---|---|---|
HR . | 95% CI . | P . | HR . | 95% CI . | P . | |
Recipient CMV serology | ||||||
Negative | 1 | — | — | 1 | — | — |
Positive | 1.67 | 0.96-2.91 | .072 | 3.13 | 0.85-11.52 | .087 |
Donor-recipient pairs | ||||||
Others | 1 | — | — | 1 | — | — |
Female → male | 2.11 | 1.78-3.80 | .012 | 3.89 | 1.27-11.82 | .017 |
Variable . | GVHD II-IV . | GVHD III-IV . | ||||
---|---|---|---|---|---|---|
HR . | 95% CI . | P . | HR . | 95% CI . | P . | |
Recipient CMV serology | ||||||
Negative | 1 | — | — | 1 | — | — |
Positive | 1.67 | 0.96-2.91 | .072 | 3.13 | 0.85-11.52 | .087 |
Donor-recipient pairs | ||||||
Others | 1 | — | — | 1 | — | — |
Female → male | 2.11 | 1.78-3.80 | .012 | 3.89 | 1.27-11.82 | .017 |
Table reflects only those variables that remained in the final multivariate model. — indicates not applicable.